Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,031Revenue $M0Net Margin (%)0Z-Score49.6
Enterprise Value $M898EPS $-2.9Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book7.410-y EBITDA Growth Rate %0Quick Ratio8.1Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio8.1Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-84.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-93.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M36.0ROI % (ttm)-77.5Gross Margin Increase y-yN

Gurus Latest Trades with TSRO

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

TSRO is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!

TSRO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Alleva Lawrence MDirector 2013-07-31Buy1,449$34.33-18.09 view
BARRETT M JAMES10% Owner 2013-06-10Sell415$40.49-30.55 view
Weller Harry R10% Owner 2013-06-10Sell560$41.45-32.16 view
BARRETT M JAMES10% Owner 2013-06-05Sell3,583$39-27.9 view
BASKETT FOREST10% Owner 2013-06-05Sell4,296$39.15-28.17 view
SANDELL SCOTT D10% Owner 2013-06-05Sell4,412$39.31-28.47 view
DRANT RYAN D10% Owner 2013-06-05Sell4,163$39.16-28.19 view
BARRIS PETER J10% Owner 2013-06-05Sell3,583$39-27.9 view
Alleva Lawrence MDirector 2013-04-30Buy1,050$28.10.07 view
Alleva Lawrence MDirector 2012-11-01Buy3,240$15.4582.01 view

Press Releases about TSRO :

    Quarterly/Annual Reports about TSRO:

    News about TSRO:

    Articles On GuruFocus.com

    More From Other Websites
    TESARO Seeks FDA Approval for NK-1 Receptor Rolapitant Sep 09 2014
    OPKO Licensee TESARO Submits New Drug Application for Rolapitant Sep 08 2014
    TESARO Announces Submission of Rolapitant New Drug Application (NDA) to U.S. Food and Drug... Sep 08 2014
    TESARO Announces Participation at Several Upcoming Investor Conferences Aug 21 2014
    TESARO, INC. Financials Aug 01 2014
    TESARO (TSRO) Slips on Wider-than-Expected Q2 Loss Jul 30 2014
    TESARO, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jul 28 2014
    TESARO, INC. Files SEC form 10-Q, Quarterly Report Jul 25 2014
    TESARO, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Jul 24 2014
    TESARO Announces Second-Quarter 2014 Operating Results Jul 24 2014
    TESARO Appoints Mary Lynne Hedley, Ph.D., as Chief Operating Officer Jul 24 2014
    Q2 2014 TESARO Inc Earnings Release - After Market Close Jul 24 2014
    Myriad Genetics Poised on Strong Fundamentals Jul 10 2014
    TESARO to Announce Second-Quarter 2014 Financial Results on July 24, 2014 Jul 10 2014
    [video] Biotech buys right now Jul 08 2014
    Tesaro (TSRO) in Focus: Stock Moves 8.9% Higher Jul 02 2014
    TESARO Summarizes Rolapitant Data Presented at the 2014 MASCC/ISOO International Symposium on... Jun 27 2014
    Cancer drug setback tarnishes AstraZeneca's R&D claims Jun 26 2014
    TESARO, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... May 27 2014
    TESARO appoints Tim Pearson as CFO May 27 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial